Your browser is no longer supported. Please, upgrade your browser.
Settings
ABC [NYSE]
AmerisourceBergen Corporation
IndexS&P 500 P/E- EPS (ttm)-18.43 Insider Own0.10% Shs Outstand206.16M Perf Week-2.21%
Market Cap24.72B Forward P/E11.31 EPS next Y10.57 Insider Trans-52.66% Shs Float148.49M Perf Month-1.43%
Income-3743.80M PEG- EPS next Q2.36 Inst Own65.80% Short Float1.01% Perf Quarter-2.58%
Sales204.32B P/S0.12 EPS this Y-530.90% Inst Trans-0.34% Short Ratio1.96 Perf Half Y-1.40%
Book/sh0.18 P/B664.17 EPS next Y14.48% ROA-7.80% Target Price141.46 Perf Year22.43%
Cash/sh12.35 P/C9.68 EPS next 5Y12.35% ROE764.10% 52W Range92.24 - 128.87 Perf YTD22.29%
Dividend1.76 P/FCF11.22 EPS past 5Y8.70% ROI-105.20% 52W High-6.31% Beta0.49
Dividend %1.47% Quick Ratio0.60 Sales past 5Y6.90% Gross Margin3.00% 52W Low30.90% ATR2.36
Employees22000 Current Ratio0.90 Sales Q/Q17.70% Oper. Margin-2.10% RSI (14)49.30 Volatility1.38% 2.13%
OptionableYes Debt/Eq186.92 EPS Q/Q-0.70% Profit Margin-1.80% Rel Volume0.73 Prev Close119.55
ShortableYes LT Debt/Eq174.93 EarningsNov 04 BMO Payout- Avg Volume768.51K Price120.74
Recom2.30 SMA200.47% SMA50-0.38% SMA2003.72% Volume124,651 Change1.00%
Feb-04-21Upgrade Evercore ISI In-line → Outperform
Jan-06-21Upgrade BofA Securities Underperform → Neutral
Jun-15-20Upgrade Morgan Stanley Equal-Weight → Overweight $112
Apr-23-20Resumed Credit Suisse Outperform $105
Apr-01-20Upgrade JP Morgan Neutral → Overweight $93 → $106
Feb-07-20Upgrade Robert W. Baird Neutral → Outperform $112
Sep-12-19Initiated Deutsche Bank Hold
Apr-11-19Initiated Guggenheim Buy
Apr-10-19Downgrade Evercore ISI Outperform → In-line
Apr-10-19Downgrade BofA/Merrill Buy → Underperform
Jan-17-19Initiated UBS Buy $89
Jul-20-18Downgrade Robert W. Baird Outperform → Neutral
Mar-08-18Initiated Barclays Equal Weight $104
Feb-27-18Resumed BofA/Merrill Buy
Feb-08-18Reiterated Needham Buy $117 → $113
Feb-07-18Reiterated Credit Suisse Outperform $105 → $112
Jan-30-18Reiterated Needham Buy $108 → $117
Jan-23-18Reiterated Needham Buy $88 → $108
Jan-05-18Initiated Evercore ISI Outperform
Dec-15-17Upgrade Goldman Neutral → Buy
Oct-27-21 08:47AM  
Oct-22-21 12:25PM  
Oct-21-21 06:45AM  
Oct-13-21 10:00AM  
Oct-06-21 08:14AM  
Oct-05-21 04:15PM  
12:04PM  
Sep-28-21 01:03PM  
Sep-27-21 09:03AM  
Sep-26-21 08:39PM  
Sep-07-21 08:44AM  
Sep-03-21 11:31AM  
Sep-02-21 04:15PM  
Aug-23-21 09:58PM  
06:38PM  
Aug-12-21 08:22AM  
Aug-10-21 06:13AM  
Aug-06-21 01:08AM  
Aug-04-21 03:30PM  
08:53AM  
07:45AM  
06:42AM  
06:30AM  
Aug-03-21 08:50AM  
08:44AM  
Aug-02-21 09:27AM  
Jul-28-21 03:03PM  
08:32AM  
Jul-27-21 10:13AM  
06:00AM  
Jul-26-21 12:25PM  
12:10PM  
Jul-23-21 12:36PM  
Jul-22-21 09:26AM  
Jul-21-21 04:56PM  
02:15PM  
05:15AM  
Jul-20-21 04:05PM  
10:47AM  
10:27AM  
09:46AM  
09:41AM  
09:17AM  
06:31AM  
01:47AM  
Jul-08-21 09:37AM  
07:48AM  
06:59AM  
Jun-24-21 04:15PM  
Jun-23-21 04:13PM  
Jun-21-21 12:18PM  
09:25AM  
Jun-09-21 09:24AM  
Jun-04-21 04:15PM  
11:31AM  
07:25AM  
Jun-03-21 12:58PM  
Jun-02-21 07:00AM  
May-26-21 08:51AM  
May-10-21 03:54PM  
May-07-21 03:01PM  
May-06-21 10:49AM  
May-05-21 04:34PM  
02:12PM  
08:24AM  
07:45AM  
06:45AM  
06:42AM  
06:30AM  
May-04-21 12:47PM  
08:54AM  
08:52AM  
08:35AM  
Apr-30-21 01:49PM  
10:29AM  
10:26AM  
Apr-29-21 09:04AM  
Apr-28-21 12:34PM  
Apr-26-21 12:10PM  
Apr-23-21 08:45AM  
Apr-22-21 08:04AM  
Apr-21-21 08:34AM  
Apr-20-21 09:49AM  
09:15AM  
Apr-19-21 11:29AM  
Apr-14-21 09:40AM  
Apr-08-21 12:00PM  
Apr-01-21 04:15PM  
Mar-30-21 05:35PM  
Mar-26-21 10:43AM  
Mar-25-21 06:41PM  
10:36AM  
Mar-24-21 04:53PM  
Mar-21-21 09:46PM  
Mar-15-21 04:29PM  
09:26AM  
Mar-06-21 11:31AM  
Mar-01-21 02:50PM  
Feb-25-21 06:45AM  
Feb-18-21 07:15AM  
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Conshohocken, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COLLIS STEVEN HChairman, President & CEOOct 12Option Exercise87.5324,2652,123,979208,844Oct 14 04:16 PM
COLLIS STEVEN HChairman, President & CEOOct 12Sale119.7924,2652,906,704184,579Oct 14 04:16 PM
COLLIS STEVEN HChairman, President & CEOSep 20Option Exercise87.5324,2652,123,979208,844Sep 22 04:11 PM
COLLIS STEVEN HChairman, President & CEOSep 20Sale121.9024,2652,957,904184,579Sep 22 04:11 PM
Krikorian LazarusSVP & Chief Accounting OfficerSep 02Option Exercise98.2417,6731,736,19632,488Sep 03 04:12 PM
Krikorian LazarusSVP & Chief Accounting OfficerSep 02Sale124.5117,6732,200,46514,815Sep 03 04:12 PM
Chou John G.Executive Vice PresidentAug 19Option Exercise88.716,081539,44673,182Aug 23 04:04 PM
Chou John G.Executive Vice PresidentAug 19Sale117.946,081717,19367,101Aug 23 04:04 PM
COLLIS STEVEN HChairman, President & CEOAug 17Option Exercise98.2412,7841,255,900197,363Aug 19 04:31 PM
COLLIS STEVEN HChairman, President & CEOAug 17Sale120.5312,7841,540,856184,579Aug 19 04:31 PM
COLLIS STEVEN HChairman, President & CEOAug 10Option Exercise88.7118,6661,655,861205,491Aug 12 04:13 PM
COLLIS STEVEN HChairman, President & CEOAug 10Sale118.6620,9122,481,418184,579Aug 12 04:13 PM
Battaglia SilvanaExecutive Vice PresidentAug 06Option Exercise86.094,515388,6965,020Aug 09 04:06 PM
Battaglia SilvanaExecutive Vice PresidentAug 06Sale121.954,655567,677365Aug 09 04:06 PM
COLLIS STEVEN HChairman, President & CEOJul 20Option Exercise98.2412,7841,255,900199,609Jul 21 04:04 PM
COLLIS STEVEN HChairman, President & CEOJul 20Sale117.6612,7841,504,165186,825Jul 21 04:04 PM
Chou John G.Executive Vice PresidentJul 19Option Exercise88.716,082539,53473,183Jul 20 04:08 PM
Chou John G.Executive Vice PresidentJul 19Sale112.096,082681,73167,101Jul 20 04:08 PM
COLLIS STEVEN HChairman, President & CEOJul 13Option Exercise88.7118,6661,655,861207,737Jul 14 04:09 PM
COLLIS STEVEN HChairman, President & CEOJul 13Sale114.9020,9122,402,789186,825Jul 14 04:09 PM
Chou John G.Executive Vice PresidentJun 18Option Exercise88.716,082539,53473,183Jun 21 04:15 PM
Chou John G.Executive Vice PresidentJun 18Sale117.236,082712,99367,101Jun 21 04:15 PM
COLLIS STEVEN HChairman, President & CEOJun 15Option Exercise98.2412,7841,255,900201,855Jun 17 04:02 PM
COLLIS STEVEN HChairman, President & CEOJun 15Sale118.8212,7841,518,995189,071Jun 17 04:02 PM
COLLIS STEVEN HChairman, President & CEOJun 08Option Exercise88.7118,6671,655,950209,984Jun 10 04:20 PM
COLLIS STEVEN HChairman, President & CEOJun 08Sale117.6520,9132,460,414189,071Jun 10 04:20 PM
Chou John G.Executive Vice PresidentMay 19Option Exercise88.716,082539,53473,183May 20 04:08 PM
Chou John G.Executive Vice PresidentMay 19Sale116.716,082709,83067,101May 20 04:08 PM
COLLIS STEVEN HChairman, President & CEOMay 18Option Exercise98.2412,7841,255,900204,101May 19 04:44 PM
COLLIS STEVEN HChairman, President & CEOMay 18Sale116.3512,7841,487,418191,317May 19 04:44 PM
COLLIS STEVEN HChairman, President & CEOMay 11Option Exercise88.7118,6671,655,950212,230May 13 04:11 PM
COLLIS STEVEN HChairman, President & CEOMay 11Sale120.7420,9132,525,036191,317May 13 04:11 PM
COLLIS STEVEN HChairman, President & CEOApr 20Option Exercise98.2412,7841,255,900206,347Apr 22 04:01 PM
COLLIS STEVEN HChairman, President & CEOApr 20Sale120.0712,7841,534,975193,563Apr 22 04:01 PM
Cleary James FChief Financial OfficerApr 19Option Exercise98.9924,1822,393,76750,647Apr 21 05:03 PM
Chou John G.Executive Vice PresidentApr 19Option Exercise88.716,082539,53473,183Apr 21 04:03 PM
Chou John G.Executive Vice PresidentApr 19Sale120.006,082729,84067,101Apr 21 04:03 PM
COLLIS STEVEN HChairman, President & CEOApr 13Option Exercise88.7118,6671,655,950214,477Apr 14 04:05 PM
COLLIS STEVEN HChairman, President & CEOApr 13Sale116.9620,9142,446,101193,563Apr 14 04:05 PM
Clark GinaExecutive Vice PresidentApr 01Sale117.949,0131,062,99317,892Apr 05 04:01 PM
Chou John G.Executive Vice PresidentMar 19Option Exercise88.716,082539,53473,183Mar 22 04:05 PM
Chou John G.Executive Vice PresidentMar 19Sale115.356,082701,55967,101Mar 22 04:05 PM
COLLIS STEVEN HChairman, President & CEOMar 16Option Exercise92.5831,4502,911,751229,507Mar 17 04:07 PM
COLLIS STEVEN HChairman, President & CEOMar 16Sale112.7133,6973,797,989195,810Mar 17 04:07 PM
Krikorian LazarusSVP & Chief Accounting OfficerMar 08Option Exercise75.6116,2361,227,60431,051Mar 09 04:03 PM
Krikorian LazarusSVP & Chief Accounting OfficerMar 08Sale108.4816,2361,761,28114,815Mar 09 04:03 PM
McGee Henry Wadsworth IIIDirectorMar 05Sale105.015,801609,16010,901Mar 08 04:42 PM
COLLIS STEVEN HChairman, President & CEOFeb 10Option Exercise88.711,419125,879199,476Feb 11 04:09 PM
COLLIS STEVEN HChairman, President & CEOFeb 10Sale108.081,419153,366198,057Feb 11 04:09 PM
COLLIS STEVEN HChairman, President & CEOFeb 08Option Exercise88.7170062,097198,757Feb 09 04:08 PM
HYLE KATHLEEN WDirectorFeb 08Option Exercise37.433,085115,47215,477Feb 09 04:10 PM
HYLE KATHLEEN WDirectorFeb 08Sale108.793,085335,61712,392Feb 09 04:10 PM
COLLIS STEVEN HChairman, President & CEOFeb 08Sale110.0870077,056198,057Feb 09 04:08 PM
COLLIS STEVEN HChairman, President & CEOFeb 05Option Exercise88.7173,9516,560,193282,008Feb 09 04:08 PM
COLLIS STEVEN HChairman, President & CEOFeb 05Sale110.3683,9519,264,832198,057Feb 09 04:08 PM
Mauch Robert P.Executive Vice PresidentJan 06Option Exercise88.7116,5611,469,12638,363Jan 07 04:16 PM
Mauch Robert P.Executive Vice PresidentJan 06Sale105.0616,5611,739,89921,802Jan 07 04:16 PM
Mauch Robert P.Executive Vice PresidentDec 14Option Exercise75.6159,0414,464,09099,362Dec 16 09:38 AM
Mauch Robert P.Executive Vice PresidentDec 14Sale98.0277,5607,602,43121,802Dec 16 09:38 AM
Chou John G.Executive Vice PresidentNov 09Option Exercise68.495,602383,68157,397Nov 10 04:01 PM
Chou John G.Executive Vice PresidentNov 09Sale108.425,602607,36951,795Nov 10 04:01 PM